Table 2.

Demographic and clinical characteristics of the participants

Characteristic (unit of measure) or [range]	HA (n = 20)	CHF (n = 12)	COPD (n = 17)	MS (n = 20)	PD (n = 20)	PFF (n = 19)
Number of walking bouts included in the analyses (n)	1343	416	1031	795	681	684
Age (years)	71.7 ± 5.8	69.1 ± 11.7	69.4 ± 9.1	48.7 ± 9.7	69.8 ± 7.2	80.0 ± 8.5
Height (cm)	1.66 ± 0.10	1.74 ± 0.10	1.69 ± 0.07	1.71 ± 0.13	1.73 ± 0.07	1.69 ± 0.08
Weight (kg)	75.1 ± 11.8	84.5 ± 16.8	73.7 ± 14.2	84.0 ± 22.9	78.2 ± 14.4	68.4 ± 16.0
Gender: % females [females n, males n]	45% [9, 11]	33% [4, 8]	47% [8, 9]	45% [9, 11]	20% [4, 16]	58% [8, 11]
WS during the 2.5-h assessment (mean and [range]) (m/s)	0.59 [0.12, 1.63]	0.72 [0.14, 1.46]	0.60 [0.11, 1.36]	0.58 [0.15, 1.60]	0.60 [0.10, 1.44]	0.54 [0.14, 1.29]
Walking Aid use: % of users [n]	5% [1]	25% [3]	6% [1]	25% [5]	30% [6]	68% [13]
MoCA [0–30]	27.7 ± 2.6	27.1 ± 2.9	24.6 ± 3.4	26.7 ± 3.1	24.6 ± 4.0	24.1 ± 4.2
LLFDI [0–100]	73.53 ± 14.22	67.29 ± 21.35	59.07 ± 7.96	57.34 ± 10.66	60.26 ± 12.51	52.59 ± 16.61
Hoehn & Yahr stage (n)					H&Y I: 4 H&Y II: 11 H&Y III: 5
MDS-UPDRS III [0–132]					28.4 ± 13.6
EDSS [0–6]				3.5 ± 1.7
SPPB [0–12]						6.2 ± 3.9
CAT Score [0–40]			16.6 ± 8.9
FEV1 (litres)			1.6 ± 0.6
6MWT distance (m)		370.7 ± 115.6	357.6 ± 88.5
KCCQ-12 Score [0–100]		80.5 ± 20.2

Values are presented as mean ± standard deviation, unless otherwise stated

CAT chronic obstructive pulmonary disease (COPD) Assessment Test; EDSS Expanded Disability Status Scale; FEV1 Forced Expiratory Volume in 1 Second; KCCQ-12 Kansas City Cardiomyopathy Questionnaire-12; LLFDI Late Life Function and Disability Instrument; MDS-UPDRS III Movement Disorder Society Unified Parkinson’s Disease Rating Scale Part III; MoCA Montreal Cognitive Assessment; SPPB Short Physical Performance Battery; 6MWT 6 Minute Walking Test; HA healthy adults; PD Parkinson’s disease; MS multiple sclerosis; COPD chronic obstructive pulmonary disease; CHF congestive heart failure; PFF proximal femoral fracture